Mechanism of Action of Empagliflozin
Introduction Empagliflozin is an oral sodium–glucose co-transporter 2 (SGLT2) inhibitor that lowers blood glucose by promoting urinary glucose … Read more
SGLT2 Inhibitor
Mechanism of Action of Dapagliflozin
Introduction Dapagliflozin is an oral sodium–glucose co-transporter 2 (SGLT2) inhibitor, used to treat type 2 diabetes mellitus (T2DM). … Read more
Mechanism of Action of Jardiance (Empagliflozin)
Introduction Jardiance (empagliflozin) is a sodium–glucose co-transporter 2 (SGLT2) inhibitor used for type 2 diabetes mellitus (T2DM), heart failure … Read more
Mechanism of Action of Farxiga (Dapagliflozin)
Introduction Dapagliflozin (trade name Farxiga) is a sodium–glucose co‑transporter 2 (SGLT2) inhibitor used in type 2 diabetes mellitus (T2DM) and … Read more